St. Clair Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
St. Clair Advisors's AMGN Position: Q3 2026 in Review
St. Clair Advisors reduced its Amgen (AMGN) stake by 0.92% in Q3 2026, selling an estimated $10K and leaving 2,700 shares worth $1.14M. The position accounts for 0.28% of the portfolio, ranked #44.
St. Clair Advisors first reported a position in AMGN in Q4 2020 and has held it in 17 quarters since. 1,057 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- St. Clair Advisors held 2,700 shares of Amgen worth $1.14M as of Q3 2026.
- St. Clair Advisors sold 25 Amgen shares in Q3 2026, an estimated $10K.
- Amgen made up 0.28% of St. Clair Advisors's portfolio in Q3 2026, its #44 holding.
- St. Clair Advisors first reported a position in Amgen in Q4 2020 and has held it in 17 quarters since.
- 1,057 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on St. Clair Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.